$3.59 Billion is the total value of Slate Path Capital LP's 50 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NYT | NEW YORK TIMES COcl a | $62,129,600 | +4.6% | 1,508,000 | 0.0% | 1.73% | -20.3% | |
| STNE | STONECO LTD | $57,361,920 | -16.2% | 5,376,000 | 0.0% | 1.60% | -36.1% | |
| VAL | VALARIS LTDcl a | $34,865,700 | +19.1% | 465,000 | 0.0% | 0.97% | -9.2% | |
| INVIVYD INC | $6,349,500 | +61.9% | 3,735,000 | 0.0% | 0.18% | +23.8% | ||
| CUE | CUE BIOPHARMA INC | $5,525,647 | -37.0% | 2,402,455 | 0.0% | 0.15% | -52.0% | |
| CYCLERION THERAPEUTICS INC | $1,223,950 | -17.0% | 357,880 | 0.0% | 0.03% | -37.0% | ||
| PLG | PLATINUM GROUP METALS LTD | $1,017,000 | -20.4% | 900,000 | 0.0% | 0.03% | -40.4% | |
| NEXI | NEXIMMUNE INC | $194,158 | -25.5% | 925,000 | 0.0% | 0.01% | -50.0% | |
| AURORA INNOVATION INC*w exp 11/03/202 | $140,000 | -36.0% | 437,500 | 0.0% | 0.00% | -50.0% | ||
| BENSON HILL INC*w exp 09/29/202 | $8,250 | -83.3% | 250,000 | 0.0% | 0.00% | -100.0% | ||
| BLUAWS | BLUERIVER ACQUISITION CORP*w exp 01/04/202 | $13,040 | +92.9% | 200,000 | 0.0% | 0.00% | – | |
| HIPPO HLDGS INC*w exp 08/02/202 | $9,450 | -28.4% | 350,000 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.